{"id":566512,"date":"2026-09-11T04:00:00","date_gmt":"2026-09-11T02:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/immunotherapy-and-molecular-targets\/"},"modified":"2026-09-17T21:43:27","modified_gmt":"2026-09-17T19:43:27","slug":"immunotherapy-and-molecular-targets","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/immunotherapy-and-molecular-targets\/","title":{"rendered":"Immunotherapy and Molecular Targets"},"content":{"rendered":"\n

New immunotherapy strategies for soft tissue sarcomas were presented at the 2026 ASCO Annual Meeting. The focus was on biomarker-based approaches using pembrolizumab and PD-L1 inhibition, which are also gaining increasing therapeutic relevance in other tumor types. The data show that immunological and molecular markers could play a decisive role in the treatment of sarcomas of the upper extremities in the future.<\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

New immunotherapy strategies for soft tissue sarcomas were presented at the 2026 ASCO Annual Meeting. The focus was on biomarker-based approaches using pembrolizumab and PD-L1 inhibition, which are also gaining……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":566513,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Soft-tissue sarcomas of the upper extremities","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11513,11370,11503],"tags":[13687,101880,101875,101878,101860,101862,70915,101869,13546,28453,101423,101866,15767,101873,101871,101864],"powerkit_post_featured":[],"class_list":["post-566512","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-congress-reports","category-oncology","category-studies","tag-biomarker-en","tag-biomarker-based-strategies","tag-doxorubicin-and-durvalumab","tag-durvalumab-plus-tremelimumab","tag-epidemiological-analyses","tag-genetic-alterations","tag-immune-checkpoint-inhibition","tag-immunological-microenvironment","tag-immunotherapy","tag-lifestyle-factors","tag-next-generation-sequencing-ngs-2","tag-pd-l1-expression","tag-pembrolizumab-en","tag-precision-medicine-treatment-approaches","tag-sarcoma-immunology","tag-soft-tissue-sarcomas-of-the-upper-extremities","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-26 22:46:41","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":566516,"slug":"immunotherapie-et-cibles-moleculaires","post_title":"Immunoth\u00e9rapie et cibles mol\u00e9culaires","href":"https:\/\/medizinonline.com\/fr\/immunotherapie-et-cibles-moleculaires\/"},"it_IT":{"locale":"it_IT","id":566522,"slug":"immunoterapia-e-bersagli-molecolari","post_title":"Immunoterapia e bersagli molecolari","href":"https:\/\/medizinonline.com\/it\/immunoterapia-e-bersagli-molecolari\/"},"pt_PT":{"locale":"pt_PT","id":566531,"slug":"imunoterapia-e-alvos-moleculares","post_title":"Imunoterapia e alvos moleculares","href":"https:\/\/medizinonline.com\/pt-pt\/imunoterapia-e-alvos-moleculares\/"},"es_ES":{"locale":"es_ES","id":566542,"slug":"inmunoterapia-y-dianas-moleculares","post_title":"Inmunoterapia y dianas moleculares","href":"https:\/\/medizinonline.com\/es\/inmunoterapia-y-dianas-moleculares\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/566512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=566512"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/566512\/revisions"}],"predecessor-version":[{"id":566514,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/566512\/revisions\/566514"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/566513"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=566512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=566512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=566512"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=566512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}